Bryan Kee

Bryan Kee is a Senior Professor at The University of Texas MD Anderson Cancer Center. His research focuses on colorectal cancer, with specific emphasis on metastasis, oncogenes, and pharmacology. His recent work investigates clinical predictors of brain metastases, circulating tumor DNA (ctDNA)-defined minimal residual disease (MRD), and novel combination therapies, including TAS-102 with celecoxib, TROP2 CAR-engineered NK cells with cetuximab, and encorafenib, cetuximab, and nivolumab in BRAFV600E metastatic colorectal cancer. He also studies aspirin use and PI3K mutations in metastatic disease, and BRAF-mutant appendiceal adenocarcinoma. His publications appear in leading journals including the Journal of Clinical Oncology and Cancer Cell.